SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.45-2.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who started this subject2/25/2004 10:28:09 PM
From: zeta1961  Read Replies (1) of 52153
 
McClellan appointment:

From biocentury.

Sen. Byron Dorgan (D-N.D.) said he will hold up the nomination of FDA Commissioner Mark McClellan to head the Centers for Medicare & Medicaid Services (CMS) until McClellan answers questions about his opposition to reimportation of prescription drugs from Canada. A spokesperson for Dorgan told BioCentury that the senator wants to know why McClellan "has been such an advocate of the industry he's supposed to regulate."

FDA's position on reimports is that it cannot ensure the safety of drugs bought from outside the U.S. Last week, the White House announced that President George Bush will nominate McClellan for the top job at CMS, and that the appointment will require Senate confirmation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News